Skip to main content
. Author manuscript; available in PMC: 2020 Sep 8.
Published in final edited form as: J Pediatr Urol. 2019 Nov 6;16(1):81–88. doi: 10.1016/j.jpurol.2019.10.030

Table 3.

UV and MV survival analysis for LN-positive patients (n = 174).

UV
MV
Hazard
Ratio
95% Lower CL 95% Upper CL P-Value Hazard
Ratio
95% Lower CL 95% Upper CL P-Value
Age (Continuous) 1.047 0.974 1.126 0.215 1.040 0.952 1.136 0.383
Gender
 Male 1.000
 Female 1.195 0.524 2.726 0.672 1.545 0.633 3.772 0.340
Race
 White 1.000
 Other 1.593 0.698 3.634 0.268 1.656 0.706 3.886 0.246
Tumor Size Laterality 1.124 1.003 1.258 0.044 1.120 1.005 1.247 0.040
 Left 1.000
 Right 0.655 0.258 1.661 0.373 0.680 0.264 1.752 0.424
SEER Summary Stage
 Regional 1.000
 Distant 1.491 0.658 3.380 0.339 1.304 0.558 3.048 0.540
LNY
 ≤6 LNs 1.000
 >6 LNs 0.762 0.334 1.739 0.519 1.227 0.468 3.217 0.678
LND (Continuous) 3.915 1.085 14.125 0.037 3.753 0.851 16.545 0.081